Company Login
Site Newsletter
pharmiweb.com today archive
1102 PWToday Stories
20 Nov 08 | Sanofi-aventis Announces the Settlement of Nasacort® AQ U.S. Patent Litigation and Certain Allegra®/Allegra® D-12 U.S. Patent Litigations
19 Nov 08 | Phase III Studies Show That Vandetanib (ZACTIMA) Brings Clinical Benefits to Patients With Lung Cancer
17 Nov 08 | Pharmaceutical Companies Need To Speed Up Transformation To Meet Changing Market Dynamics, Says Ernst & Young Report
17 Nov 08 | Pharmaceutical Companies Need To Speed Up Transformation To Meet Changing Market Dynamics, Says Ernst & Young Report
14 Nov 08 | GARDASIL®, Merck's Cervical Cancer Vaccine, Demonstrated Efficacy in Preventing HPV-Related Disease in Males in Phase III Study
13 Nov 08 | SEROQUEL XR and SEROQUEL Approved in Europe for New Indications for the Treatment of Bipolar Disorder
11 Nov 08 | GSK and Xenoport announce plans to withdraw and resubmit new drug application requesting approval of Solziraâ„¢ for restless legs syndrome
03 Nov 08 | Pfizer’s TOVIAZ™ (fesoterodine fumarate) Receives FDA Approval for the Treatment of Overactive Bladder
29 Oct 08 | Pfizer’s Novel HIV/AIDS Treatment Selzentry™ (Maraviroc) Demonstrates Increased Efficacy Rate In Treatment-Naïve HIV Patients
24 Oct 08 | GSK receives positive CHMP opinion for new non-prescription weight loss treatment – alli® – to help in the fight against obesity across Europe
23 Oct 08 | Dynavax and Merck & Co., Inc. Provide Update on U.S. FDA Clinical Hold on Investigational Vaccine HEPLISAVâ„¢
21 Oct 08 | AstraZeneca Announces European SEROQUEL XR Submission for the Treatment of Generalised Anxiety Disorder
20 Oct 08 | Boehringer Ingelheim’s pipeline update unveils novel investigational compounds heralding the Company’s entry into Type 2 Diabetes
